Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning

被引:39
作者
Noureddin, Mazen [1 ]
Ntanios, Fady [2 ]
Malhotra, Deepa [2 ]
Hoover, Katherine [2 ]
Emir, Birol [2 ]
McLeod, Euan [3 ]
Alkhouri, Naim [4 ]
机构
[1] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Karsh Div Gastroenterol & Hepatol, 8900 Beverly Blvd Suite 250, Los Angeles, CA 90048 USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Ltd, Tadworth, England
[4] Arizona Liver Hlth, Chandler, AZ USA
关键词
NONALCOHOLIC FATTY LIVER; DISEASE; STEATOHEPATITIS; EPIDEMIOLOGY; FIBROSIS; ASSOCIATION; MORTALITY; RISK;
D O I
10.1002/hep4.1935
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This cohort analysis investigated the prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD with fibrosis at different stages, associated clinical characteristics, and comorbidities in the general United States population and a subpopulation with type 2 diabetes mellitus (T2DM), using the National Health and Nutrition Examination Survey (NHANES) database (2017-2018). Machine learning was explored to predict NAFLD identified by transient elastography (FibroScan(R)). Adults >= 20 years of age with valid transient elastography measurements were included; those with high alcohol consumption, viral hepatitis, or human immunodeficiency virus were excluded. Controlled attenuation parameter >= 302 dB/m using Youden's index defined NAFLD; vibration-controlled transient elastography liver stiffness cutoffs were <= 8.2, <= 9.7, <= 13.6, and >13.6 kPa for F0-F1, F2, F3, and F4, respectively. Predictive modeling, using six different machine-learning approaches with demographic and clinical data from NHANES, was applied. Age-adjusted prevalence of NAFLD and of NAFLD with F0-F1 and F2-F4 fibrosis was 25.3%, 18.9%, and 4.4%, respectively, in the overall population and 54.6%, 32.6%, and 18.3% in those with T2DM. The highest prevalence was among Mexican American participants. Test performance for all six machine-learning models was similar (area under the receiver operating characteristic curve, 0.79-0.84). Machine learning using logistic regression identified male sex, hemoglobin A1c, age, and body mass index among significant predictors of NAFLD (P <= 0.01). Conclusion: Data show a high prevalence of NAFLD with significant fibrosis (>= F2) in the general United States population, with greater prevalence in participants with T2DM. Using readily available, standard demographic and clinical data, machine-learning models could identify subjects with NAFLD across large data sets.
引用
收藏
页码:1537 / 1548
页数:12
相关论文
共 35 条
  • [1] Imaging biomarkers of NAFLD, NASH, and fibrosis
    Ajmera, Veeral
    Loomba, Rohit
    [J]. MOLECULAR METABOLISM, 2020, 50
  • [2] [Anonymous], 2011, Age and sex composition: 2010
  • [3] Epidemiology of Non-Alcoholic Fatty Liver Disease
    Bellentani, Stefano
    Scaglioni, Federica
    Marino, Mariano
    Bedogni, Giorgio
    [J]. DIGESTIVE DISEASES, 2010, 28 (01) : 155 - 161
  • [4] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [5] Centers for Disease Control and Prevention, 2017, NAT CTR HLTH STAT NH
  • [6] Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey (NHANES), 2018, LIV ULTR TRANS EL PR
  • [7] Chalasani NP, 2017, HEPATOLOGY, V66, p303A
  • [8] Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
    Davison, Beth A.
    Harrison, Stephen A.
    Cotter, Gad
    Alkhouri, Naim
    Sanyal, Arun
    Edwards, Christopher
    Colca, Jerry R.
    Iwashita, Julie
    Koch, Gary G.
    Dittrich, Howard C.
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1322 - 1332
  • [9] Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art
    Dinani, Amreen M.
    Kowdley, Kris V.
    Noureddin, Mazen
    [J]. HEPATOLOGY, 2021, 74 (04) : 2233 - 2240
  • [10] Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
    Dulai, Parambir S.
    Singh, Siddharth
    Patel, Janki
    Soni, Meera
    Prokop, Larry J.
    Younossi, Zobair
    Sebastiani, Giada
    Ekstedt, Mattias
    Hagstrom, Hannes
    Nasr, Patrik
    Stal, Per
    Wong, Vincent Wai-Sun
    Kechagias, Stergios
    Hultcrantz, Rolf
    Loomba, Rohit
    [J]. HEPATOLOGY, 2017, 65 (05) : 1557 - 1565